BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36640905)

  • 1. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
    Mallick S; Chakrabarti J; Eschbacher J; Moraitis AG; Greenstein AE; Churko J; Pond KW; Livolsi A; Thorne CA; Little AS; Yuen KCJ; Zavros Y
    Transl Res; 2023 Jun; 256():56-72. PubMed ID: 36640905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.
    Pivonello R; Munster PN; Terzolo M; Ferrigno R; Simeoli C; Puglisi S; Bali U; Moraitis AG
    Front Endocrinol (Lausanne); 2021; 12():793262. PubMed ID: 35058882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone.
    Fleseriu M; Findling JW; Koch CA; Schlaffer SM; Buchfelder M; Gross C
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3718-27. PubMed ID: 25013998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
    Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition.
    Viho EMG; Kroon J; Feelders RA; Houtman R; van den Dungen ESR; Pereira AM; Hunt HJ; Hofland LJ; Meijer OC
    J Endocrinol; 2023 Feb; 256(2):. PubMed ID: 36445262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
    Treppiedi D; Di Muro G; Marra G; Barbieri AM; Mangili F; Catalano R; Serban A; Ferrante E; Locatelli M; Lania AG; Arosio M; Spada A; Peverelli E; Mantovani G
    Endocr Relat Cancer; 2021 Jun; 28(8):573-582. PubMed ID: 34086599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing's Disease.
    Chakrabarti J; Pandey R; Churko JM; Eschbacher J; Mallick S; Chen Y; Hermes B; Mallick P; Stansfield BN; Pond KW; Thorne CA; Yuen KCJ; Little AS; Zavros Y
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
    Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro.
    Albani A; Perez-Rivas LG; Tang S; Simon J; Lucia KE; Colón-Bolea P; Schopohl J; Roeber S; Buchfelder M; Rotermund R; Flitsch J; Thorsteinsdottir J; Herms J; Stalla G; Reincke M; Theodoropoulou M
    Endocr Relat Cancer; 2022 Aug; 29(8):503-511. PubMed ID: 35686696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of somatostatin analogs in Cushing's disease.
    van der Hoek J; Lamberts SW; Hofland LJ
    Pituitary; 2004; 7(4):257-64. PubMed ID: 16132202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pasireotide and mifepristone: new options in the medical management of Cushing's disease.
    Cohan P
    Endocr Pract; 2014 Jan; 20(1):84-93. PubMed ID: 24126229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.
    Jin K; Ruan L; Pu J; Zhong A; Wang F; Tan S; Huang H; Mu J; Yang G
    Mol Cell Endocrinol; 2018 Dec; 478():53-61. PubMed ID: 30025915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.
    Ben-Shlomo A; Schmid H; Wawrowsky K; Pichurin O; Hubina E; Chesnokova V; Liu NA; Culler M; Melmed S
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4342-50. PubMed ID: 19820006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms involved in somatostatin receptor regulation in corticotroph tumors: the role of cytoskeleton and USP8 mutations.
    Peverelli E; Treppiedi D; Mantovani G
    Endocr Oncol; 2022 Jan; 2(1):R24-R30. PubMed ID: 37435448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.
    Fleseriu M; Petersenn S
    J Neurooncol; 2013 Aug; 114(1):1-11. PubMed ID: 23673515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line.
    Gentilin E; Borges De Souza P; Ambrosio MR; Bondanelli M; Gagliardi I; Zatelli MC
    J Endocrinol Invest; 2023 Dec; 46(12):2609-2616. PubMed ID: 37233978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
    Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
    Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T; Kato M; Tani Y; Oyama K; Yamada S; Hirata Y
    Endocr J; 2009; 56(4):579-84. PubMed ID: 19318729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.